For example, several single-nucleotide polymorphisms (SNPs) in FGF2 gene were found to be associated with altered responsiveness to antidepressant treatment in individuals with MDD (Kato et al., 2009, 2015). This evidence concerns the gene FGF2 and major depressive disorder.